[Sponsored] A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices. The post Navina’s AI Copilot Eases the Value-Based Burden, Study Shows appeared first on MedCity News.
Medicaid is the main source of coverage for adults with opioid use disorder and among those receiving treatment services. Most adults with OUD in Medicaid are eligible through Medicaid expansion.
This opinion article was originally published in STAT: A failing health care system caused my husband’s death. His care team was incredibly kind, but they lacked the resources to save his life. On Tuesday, September 17, the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, and the Agency for Healthcare…
Conventional wisdom holds that alcohol use is part of American culture…but perhaps this is changing. According to a Gallup poll released last week, not only is alcohol use declining but there is an increasing perception that alcohol use is not good for you. While a majority of Americans (54%) still use alcohol, drinking rates are…
Steps that healthcare providers can take – internally and with the help of external partners – to boost both their security capabilities and the confidence of their clinicians in those capabilities The post Imaging Practices Can Restore Their Clinicians’ Cybersecurity Confidence With These Four Steps appeared first on MedCity News.
Simplifying payments isn’t just about transactions; it’s about building better relationships and ensuring financial health through protection, payment choice, scale, and integration. The post Payments Simplified: The 4 Key Features of Modern Healthcare Payment Platforms appeared first on MedCity News.
They’re the fixers, the ones who step in when Affordable Care Act enrollees have a problem with their coverage, like a newborn incorrectly left off a policy or discovering that a rogue broker had signed them up or switched their plan without consent. Specially trained caseworkers help resolve such issues, which might otherwise cause consumers…
by MIKE MAGEE THCB is back from its end of year break, but we are starting with a little catchup from December from Mike Magee. As my wife often reminds me, “Comparisons are toxic.” And, in general, I agree and try to respect this cardinal rule. But these are extraordinary times. So grant me this…
Eikon Therapeutics’ IPO haul will support a lead program that could expand the scope of cancer immunotherapy. Eikon’s stock market debut builds on growing IPO momentum, following upsized offerings from Aktis Oncology and Veradermics. The post Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials appeared first on MedCity News.
Novartis, which already has experience with RNA interference therapies, is now turning to this modality as a potential way to treat Parkinson’s disease. The pharmaceutical giant is licensing rights to an Arrowhead Pharmaceuticals RNAi therapy designed to inhibit production of alpha synuclein, a protein associated with Parkinson’s progression. The post Novartis Tries Again in Parkinson’s,…